To view this email as a web page, click here

Today's Rundown

Featured Story

Novartis powers drug delivery specialist to $40M funding round

Credence MedSystems has topped up its bank account again. With Novartis coming on board as an investor, the California-based company has reeled in $39.9 million to boost production of injectable drug delivery systems.

read more

Top Stories

BD pitches for COVID-19 vaccine market by showing prefilled syringes cope with deep cold storage

BD has positioned itself to unlock a new COVID-19 vaccine opportunity by showing its glass prefilled syringes are suitable for use with mRNA shots that need storing at ultralow temperatures. 

read more

SynAgile takes on debt to wrap up midphase trial of drug delivery dental retainer

The limitations of orally delivered levodopa have inspired a range of novel formulations designed to provide more constant levels of the drug. SynAgile has put its own spin on the molecule with a drug delivery dental retainer—and has secured debt financing to take it through phase 2.

read more

Intract signs up another oral monoclonal antibody partner

Intract Pharma has landed another oral antibody delivery partnership. Bio-Thera Solutions is the latest drug developer to strike a deal for Intract’s technology, securing itself the right to use the oral delivery system with a single undisclosed monoclonal antibody. 

read more

GlaxoSmithKline's long-acting HIV drug nabs FDA priority review as a preventative option

With a priority review designation from the FDA, GlaxoSmithKline has moved a step closer to a potential approval of cabotegravir as the first long-acting therapy for HIV pre-exposure prophylaxis (PrEP). The FDA has set a deadline for the review by January 24.

read more

Resources

Whitepaper: Big Challenges for Small Sponsors: Competition in Oncology Research

Every biopharma sponsor faces the challenge of initiating, running and closing trials on time, but oncology studies pose several unique hurdles.

Whitepaper: Applications of Digital Twins in Clinical Trials for Alzheimer’s Disease

Read Unlearn’s whitepaper to learn about how novel trial designs with Digital Twins enable more efficient clinical trials, with higher power and smaller required sample sizes.

Whitepaper: Evaluating current manufacturing platforms for recombinant AAV production

Choose the right AAV platform for your viral vector-based therapy

Whitepaper: The Value of Precision Medicine Informatics Initiatives Research Findings

Download the Value of Precision Medicine Informatics (PMI) Initiatives report to learn about the technology, data types, and the value derived from more than 100 PMI initiatives.

Whitepaper: Challenging Tradition: The Argument for Integrated Commercialization to Improve Operational Agility

Today’s economics do not allow manufactures to keep making decisions in an antiquated way. They need to challenge tradition & deliver faster, cheaper, successful launches. Learn how.

Whitepaper: High-yield NK cell culture for allogeneic cell therapy applications

Thermo Fisher Scientific introduces a new NK cell culture medium designed to support feeder-free, high-yield growth for cell therapy applications.

Whitepaper: Five Trends to Watch in the European Market Access Environment

This white paper provides a concise overview of the trends currently shaping the market access environment in Europe, as well as the implications for biopharma companies.

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Content Hub: Remarque Systems Resource Hub

Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. 

eBrief: Drug Product Process Development: Ensuring a Consistent, High-quality Biologic

Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase.

Events